Cargando…

DHODH and cancer: promising prospects to be explored

Human dihydroorotate dehydrogenase (DHODH) is a flavin-dependent mitochondrial enzyme catalyzing the fourth step in the de novo pyrimidine synthesis pathway. It is originally a target for the treatment of the non-neoplastic diseases involving in rheumatoid arthritis and multiple sclerosis, and is re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yue, Tao, Lei, Zhou, Xia, Zuo, Zeping, Gong, Jin, Liu, Xiaocong, Zhou, Yang, Liu, Chunqi, Sang, Na, Liu, Huan, Zou, Jiao, Gou, Kun, Yang, Xiaowei, Zhao, Yinglan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107416/ https://www.ncbi.nlm.nih.gov/pubmed/33971967 http://dx.doi.org/10.1186/s40170-021-00250-z

Ejemplares similares

Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51
por: Tao, Lei, et al.
Publicado: (2023)

DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia
por: Sexauer, Amy N., et al.
Publicado: (2023)

The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy
por: Liu, Huan, et al.
Publicado: (2021)

The Warburg effect modulates DHODH role in ferroptosis: a review
por: Amos, Alvan, et al.
Publicado: (2023)

DHODH tangoing with GPX4 on the ferroptotic stage
por: Wang, Fudi, et al.
Publicado: (2021)

Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B
por: Sang, Na, et al.
Publicado: (2023)

Inactivation/deficiency of DHODH induces cell cycle arrest and programed cell death in melanoma
por: Liu, Lichao, et al.
Publicado: (2017)

UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis
por: Hosseini, Mohsen, et al.
Publicado: (2019)

Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition
por: Amos, Alvan, et al.
Publicado: (2023)

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
por: Olsen, Thale Kristin, et al.
Publicado: (2022)

Correction: Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition
por: Amos, Alvan, et al.
Publicado: (2023)

Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells
por: Gong, Jin, et al.
Publicado: (2020)

Assessment of a novel variation in DHODH gene causing Miller syndrome: The first report in Chinese population
por: Yang, Kai, et al.
Publicado: (2023)

The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
por: Gaidano, Valentina, et al.
Publicado: (2021)

DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance
por: Zhang, Juan, et al.
Publicado: (2021)

17β-oestradiol inhibits ferroptosis in the hippocampus by upregulating DHODH and further improves memory decline after ovariectomy
por: Tian, Ying, et al.
Publicado: (2023)

Elevated DHODH expression promotes cell proliferation via stabilizing β-catenin in esophageal squamous cell carcinoma
por: Qian, Yu, et al.
Publicado: (2020)

Exploring Impaired SERCA Pump-Caused Alternation Occurrence in Ischemia
por: Liu, Jiaqi, et al.
Publicado: (2019)

P1280: TARGETED INHIBITION OF DHODH IS SYNERGISTIC WITH BCL2 BLOCKADE IN LYMPHOMA WITH CONCURRENT MYC AND BCL2 REARRANGEMENT
por: Mo, W., et al.
Publicado: (2022)

DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
por: Mullen, Nicholas J., et al.
Publicado: (2023)

Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer
por: Peng, Wen, et al.
Publicado: (2020)

DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway
por: Jiang, Mengying, et al.
Publicado: (2023)

Babesia bovis Dihydroorotate Dehydrogenase (BboDHODH) is a Novel Molecular Target of Drug for Bovine Babesiosis
por: KAMYINGKIRD, Ketsarin, et al.
Publicado: (2013)

Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology
por: Ladds, Marcus J. G.W., et al.
Publicado: (2021)

Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review
por: Kaur, Hardeep, et al.
Publicado: (2021)

The Novel hDHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis
por: Sibille, Giulia, et al.
Publicado: (2022)

Characterisation of putative class 1A DHODH-like proteins from Mucorales and dematiaceous mould species
por: Pinder, Corinne, et al.
Publicado: (2023)

A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses
por: Zheng, Yucheng, et al.
Publicado: (2022)

A novel series of human dihydroorotate dehydrogenase inhibitors discovered by in vitro screening: inhibition activity and crystallographic binding mode
por: Zeng, Ting, et al.
Publicado: (2019)

PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis
por: Yamaguchi, Norihiro, et al.
Publicado: (2019)

The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines
por: Luban, Jeremy, et al.
Publicado: (2021)

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH)
por: Lucas-Hourani, Marianne, et al.
Publicado: (2015)

A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
por: Ladds, Marcus J. G. W., et al.
Publicado: (2018)

Intraocular DHODH-inhibitor PP-001 suppresses relapsing experimental uveitis and cytokine production of human lymphocytes, but not of RPE cells
por: Diedrichs-Möhring, Maria, et al.
Publicado: (2018)

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis
por: Tomic, Barbara, et al.
Publicado: (2022)

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

The Mechanism of Houttuynia cordata Embryotoxicity Was Explored in Combination with an Experimental Model and Network Pharmacology
por: Liu, Yufu, et al.
Publicado: (2023)

Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation
por: Liu, Chunqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9s540egeirdtt5p1caf80hglhv